Skip to main content
. 2019 Sep 3;22(9):1032–1038. doi: 10.1089/jpm.2018.0626

Table 2.

Variations in End-of-Life Treatment Options Presented on Physician Orders for Life-Sustaining Treatment Forms (n = 45)

  Antibiotics IV fluids Transfer to hospital Medication by any route Oxygen BiPAP/CPAP Intubation/ventilation
POLST maturity status N (%) N (%) N (%) N (%) N (%) N (%) N (%)
POLST maturity status              
 Mature 2 (66.67) 3 (100) 3 (100) 3 (100) 3 (100) 3 (100) 3 (100)
 Endorsed 14 (73.68) 13 (68.42) 19 (100) 19 (100) 19 (100) 18 (94.74) 18 (94.74)
 Developing 14 (70.00) 16 (80.00) 20 (100) 20 (100) 20 (100) 18 (90) 17 (85)
 Nonconforming 2 (66.67) 1 (33.33) 3 (100) 3 (100) 3 (100) 3 (100) 3 (100)
Frequency mentioned and locations
 Mentioned once
  Comfort Measures 13 (28.89) 0 0 45 (100) 45 (100) 0 0
  Limited treatment 0 28 (62.22) 0 0 0 1 (2.22) 0
  Full treatment 15 (33.33) 0 0 0 0 10 (22.22) 36 (80)
  Separate section 0 0 4 (8.89) 0 0 0 5 (11.11)
 Mentioned twice
  Comfort + limited treatment 3 (6.67) 0 7 (15.56) 0 0 0 0
  Limited + full treatment 0 5 (11.11) 0 0 0 26 (57.78) 0
  Limited + separate section 1 (2.22) 0 0 0 0 0 0
  Full + separate section 0 0 0 0 0 0 0
 Mentioned three time
  Comfort + limited + full treatment 0 0 34 (75.56) 0 0 0 0
  Limited + full + separate section 0 0 0 0 0 0 0
 Total mentioned 32 (71.11) 33 (73.33) 45 (100) 45 (100) 45 (100) 42 (93.33) 41 (91.11)
 Not mentioned at all 13 (28.89) 12 (26.67) 0 0 0 3 (6.67) 4 (8.89)
  Total 45 (100) 45 (100) 45 (100) 45 (100) 45 (100) 45 (100) 45 (100)

BiPAP, bi-level positive airway pressure; CPAP, continuous positive airway pressure; IV, intravenous.